Greenwood Capital Associates LLC Sells 208,087 Shares of Apyx Medical Co. (NASDAQ:APYX)

Greenwood Capital Associates LLC reduced its holdings in Apyx Medical Co. (NASDAQ:APYX - Free Report) by 89.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,671 shares of the company's stock after selling 208,087 shares during the period. Greenwood Capital Associates LLC owned approximately 0.06% of Apyx Medical worth $32,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Raymond James Financial Inc. acquired a new stake in shares of Apyx Medical in the fourth quarter worth $134,000. Kingsview Wealth Management LLC boosted its holdings in Apyx Medical by 8.7% in the 4th quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company's stock valued at $214,000 after purchasing an additional 10,800 shares during the period. Citadel Advisors LLC grew its position in Apyx Medical by 130.6% in the 4th quarter. Citadel Advisors LLC now owns 66,355 shares of the company's stock worth $105,000 after purchasing an additional 37,582 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Apyx Medical by 27.9% during the 4th quarter. Northern Trust Corp now owns 132,251 shares of the company's stock worth $209,000 after purchasing an additional 28,865 shares during the period. Finally, Commonwealth Equity Services LLC increased its holdings in shares of Apyx Medical by 3.0% during the 4th quarter. Commonwealth Equity Services LLC now owns 527,061 shares of the company's stock worth $833,000 after purchasing an additional 15,500 shares during the period. 55.33% of the stock is currently owned by institutional investors and hedge funds.

Apyx Medical Stock Performance

Shares of APYX traded up $0.04 during trading hours on Friday, reaching $1.75. 33,156 shares of the company traded hands, compared to its average volume of 78,818. The company has a debt-to-equity ratio of 3.03, a quick ratio of 4.52 and a current ratio of 5.46. The stock's fifty day moving average is $1.30 and its 200 day moving average is $1.39. Apyx Medical Co. has a 1-year low of $0.76 and a 1-year high of $1.95. The stock has a market cap of $66.14 million, a P/E ratio of -2.11 and a beta of 1.21.

Apyx Medical (NASDAQ:APYX - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.03. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. The firm had revenue of $9.43 million during the quarter, compared to analysts' expectations of $9.39 million. Equities research analysts anticipate that Apyx Medical Co. will post -0.68 earnings per share for the current fiscal year.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.